Growth hormone attenuates tumor necrosis factor in burned children

Archives of Surgery

Volumn 134, Issue 3, 1999, Pages 283-286

  Chrysopoulo, Minas T ^a   Jeschke, Marc G ^a   Ramirez, Roquc J ^a   Barrow, Robert E ^a,b   Herndon, David N ^a  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b SHRINERS HOSPITALS FOR CHILDREN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN GROWTH HORMONE; PLACEBO; TUMOR NECROSIS FACTOR ALPHA;

ACUTE PHASE RESPONSE; ARTICLE; BURN; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MALE; MORTALITY; MULTIPLE ORGAN FAILURE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN METABOLISM; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; TREATMENT OUTCOME;

EID: 0033015872     PISSN: 00040010     EISSN: None     Source Type: Journal    
DOI: 10.1001/archsurg.134.3.283     Document Type: Article

References (26)

1. Petersen SR, Jeevanandam M, Shahbazian LM, Holaday NJ. Reprioritization of liver protein synthesis resulting from recombinant human growth hormone supplementation in parenterally fed trauma patients: the effect of growth hormone on the acute-phase response. J Trauma. 1997;42:987-996.
2. Beutler B, Cerami A. The common mediator of shock, cachexia, and tumor necrosis Adv Immunol. 1988;42:213-231.
3. Moldawer LL, Lowry SF, Cerami A. Cachectin: its impact on metabolism and nutritional status. Amu Rev Nutr. 1988;8:585-609.
4. Balkwill FR. Tumor necrosis factor and lymphotoxin. In: Balkwill FR, ed. Cytokines in Cancer Therapy. Oxford, England: Oxford University Press; 1989:54-87.
5. Rall LC, Rosen CJ, Dolnikowski G, et al. Protein metabolism in rheumatoid arthritis and aging: effects of muscle strength training and tumor necrosis factor α. Arthritis Rheum. 1996;39:1115-1124.
6. Marano M, Fong Y, Moldawer LL, et al. Cachectin/TNF in the serum of ICU and burn patients. Paper presented at: American Burn Association Annual Proceedings; 1988;20:18.
7. Yamada Y, Endo S, Inada K. Plasma cytokine levels in patients with severe burn injury - with reference to the relationship between infection and prognosis. Burns. 1996;22:587-593.
8. Balteskard L, Unneberg K, Halvorsen D, et al. The influence of growth hormone on tumour necrosis factor and neutrophil leukocyte function in sepsis, Scand J Infect Dis. 1997;29:393-399.
9. Liljedahl SO, Gemzell CA, Plantin LO, et al. Effect of human growth hormone in patients with severe burns. Acta Chir Scand. 1961;22:1-14.
10. Soroff HS, Rozin RR, Mooty J, Lister J, Raben MS. Role of human growth hormone in the response to trauma, I: metabolic effects following burns. Ann Surg. 1967;166:739-752.
11. Muller MJ, Gilpin DA, Herndon DN. Modulation of wound healing and the postburn response. In: Herndon DN, ed: Tolal Burn Care. Philadelphia, Pa: WB Saunders Co; 1996:223-236.
12. Wilmore DW, Moylan JA Jr, Bristow BF, Mason AD Jr, Pruitt BA Jr. Anabolic effects of growth hormone and high caloric feedings following thermal injury. Surg Gynecol Obstet. 1974;138:875-884.
13. Soroff HS, Pearson E, Green NL, et al. The effect of growth hormone on nitrogen balance at various levels of intake in burned patients. Surg Gynecol Obstet. 1960; 111:875-884.
14. Herndon DN, Barrow RE, Kunkel KR, Broemeling L, Rutan RL. Effects of recombinant human growth hormone on donor site healing in severely burned children. Ann Surg. 1990;212:424-429.
15. Fan J, Char D, Bagby GJ. Regulation of insulin-like growth factor-1 (IGF-1) and IGF-binding proteins by tumor necrosis factor. Am J Physiol. 1995;269(pt 2): R1204-R1212.
16. Chwans WJ, Bistrian BR. Role of exogenous growth hormone and insulin-like growth factor-1 in malnutrition and acute metabolic stress: a hypothesis. Crit Care Med. 1991;19:1317-1322.
17. Boulware SD, Tamborlane WV, Matthews LS, Sherwin RS. Diverse effects of insulin-like growth factor 1 on glucose, lipid, and amino acid metabolism. Am J Physiol. 1992;262(pt 1):E130-E133.
18. Gore DC, Honeycutt D, Jahoor F, Wolfe RR, Herndon DN. Effect of exogenous growth hormone on whole-body and isolated-limb protein kinetics in burned patients. Arch Surg. 1991;126:38-43.
19. Frost RA, Lang CH, Gelato MC. Transient exposure of human myoblasts to tumor necrosis factor-α inhibits serum and insulin-like growth factor 1 stimulated protein synthesis. Endocrinology. 1997;138:4153-4159.
20. Jurasinski CV, Vary TC. Insulin-like growth factor 1 accelerates protein synthesis in skeletal muscle during sepsis. Am J Physiol. 1995;269(pt 1):E977-E981.
21. Fan J, Molina PE, Gelato MC, Lang CH. Differential tissue regulation of insulin-like growth factor-1 content and binding proteins after endotoxin. Endocrinology. 1994;134:1685-1692.
22. Davies SC, Wass JAH, Ross RJM, et al. The induction of a specific protease for insulin-like growth factor binding protein-3 in the circulation during severe illness. J Endocrinol. 1991;130:469-473.
23. Ghahary A, Fu S, Shen YJ, Shankowsky HA, Tredget EE. Differential effects of thermal injury on circulating insulin-like growth factor binding proteins in burn patients. Mol Cell Biochem. 1994;135:171-180.
24. Wojnar MM, Fan J, Frost RA, Lang CH. Alterations in the insulin-like growth factor system in trauma patients. Am J Physiol. 1995;268(pt 2):R970-R977.
25. Schwander JC, Hauri C, Zapf J, Froesch ER. Synthesis and secretion of insulin-like growth factor and its binding protein by the perfused rat liver: dependence on growth hormone status. Endocrinology. 1983;113:297-305.
26. Underwood LE, D'Ercole AJ, Van Wyk JJ. Somatomedin C and the assessment of growth. Pediatr Clin North Am. 1980;27:771-782.